SERA Insider Trading Activity and SEC Form 4 Filings
SERA insider trading summary
Over the past 12 months, insiders at Sera Prognostics, Inc. (SERA) reported 49 sales worth $612K by 10 insiders and no open-market purchases on SEC Form 4. Net insider selling was $612K.
Latest SERA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 12, 2026 | Tiffany Eul Davis Inglis | Chief Medical Officer | Sell | $16K (8,024 @ $2.03) |
| Sep 10, 2026 | Dyaarl Lee Anderson Jr. | Chief Commercial Officer | Sell | $4K (1,800 @ $2.00) |
| Sep 10, 2026 | Benjamin Jackson | General Counsel | Sell | $4K (2,190 @ $2.00) |
| Sep 10, 2026 | Zhenya Lindgardt | Chief Executive Officer | Sell | $14K (7,022 @ $2.00) |
| Sep 10, 2026 | Tiffany Eul Davis Inglis | Chief Medical Officer | Sell | $972 (486 @ $2.00) |
| Jun 11, 2026 | Benjamin Jackson | General Counsel | Sell | $4K (2,179 @ $2.01) |
| Jun 11, 2026 | Dyaarl Lee Anderson Jr. | Chief Commercial Officer | Sell | $10K (4,739 @ $2.01) |
| Jun 11, 2026 | Zhenya Lindgardt | Chief Executive Officer | Sell | $14K (6,990 @ $2.01) |
| Jun 11, 2026 | Austin Aerts | Chief Financial Officer | Sell | $4K (2,037 @ $2.01) |
| Jun 11, 2026 | Tiffany Eul Davis Inglis | Chief Medical Officer | Sell | $728 (362 @ $2.01) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.